| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of APEX2 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of APEX2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APEX2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of APEX2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of APEX2 mRNA | CTD | PMID:17942748 |
| 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of APEX2 mRNA | CTD | PMID:20188158 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of APEX2 mRNA | CTD | PMID:21715664 |
| cobalt dichloride | decreases expression | ISO | RGD:1350631 | 6480464 | cobaltous chloride results in decreased expression of APEX2 mRNA | CTD | PMID:19320972 |
| copper(2+) sulfate | increases expression | ISO | RGD:1350631 | 6480464 | Copper Sulfate results in increased expression of APEX2 mRNA | CTD | PMID:19549813 |
| flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of APEX2 mRNA | CTD | PMID:19442681 |
| ketamine | decreases expression | ISO | RGD:1565983 | 6480464 | Ketamine results in decreased expression of APEX2 mRNA | CTD | PMID:20080153 |
| methamphetamine | increases expression | ISO | RGD:1565983 | 6480464 | Methamphetamine results in increased expression of APEX2 mRNA | CTD | PMID:19149911 |
| methamphetamine | increases expression | ISO | RGD:1586200 | 6480464 | Methamphetamine results in increased expression of APEX2 mRNA | CTD | PMID:19149911 |
| methyl methanesulfonate | increases expression | ISO | RGD:1350631 | 6480464 | Methyl Methanesulfonate results in increased expression of APEX2 mRNA | CTD | PMID:21527772 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of APEX2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1350631 | 6480464 | Acetaminophen results in increased expression of APEX2 mRNA | CTD | PMID:22230336 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1350631 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of APEX2 mRNA | CTD | PMID:19031421 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | NCF1 protein affects the reaction [pirinixic acid results in decreased expression of APEX2 mRNA]; more ... | CTD | PMID:17950772 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of APEX2 mRNA | CTD | PMID:17950772 |
| tamoxifen | increases expression | ISO | RGD:1350631 | 6480464 | Tamoxifen results in increased expression of APEX2 mRNA | CTD | PMID:15590111 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of APEX2 mRNA | CTD | PMID:17555576 |
| troglitazone | decreases expression | ISO | RGD:1350631 | 6480464 | troglitazone results in decreased expression of APEX2 mRNA | CTD | PMID:19140230 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of APEX2 mRNA | CTD | PMID:17963808 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of APEX2 mRNA | CTD | PMID:20546886 |